, Tracking Stock Market Picks
Enter Symbol:
Rating: GPRO
Neutral $18

Gopro Inc. (NASDAQ: GPRO) reiterated to Neutral with price target $18 by Robert W. Baird

Friday,  Dec 4, 2015  8:25 AM ET by Dave Ficere

Robert W. Baird reiterated Gopro Inc. (NASDAQ: GPRO) to Neutral with price
target $18. Previously Robert W. Baird rated Neutral with price target $83 Gopro Inc. (NASDAQ: GPRO) on 05/04/2012, when the stock price was $81.39.

Gen-Probe Inc. is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid testing (NAT) products used for the clinical diagnosis of human diseases and for screening donated human blood. Using its patented NAT technology, Gen-Probe has received FDA approvals for more than 40 products that detect a wide variety of infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia and fungal infections.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy